目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global anticoagulants market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global anticoagulants market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral anticoagulants - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
6.4 Injectable anticoagulants - Market size and forecast 2022-2027
Exhibit 38: Chart on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)
Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022-2027 (%)
Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Factor Xa inhibitors - Market size and forecast 2022-2027
Exhibit 48: Chart on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
7.4 DTIs - Market size and forecast 2022-2027
Exhibit 52: Chart on DTIs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on DTIs - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on DTIs - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on DTIs - Year-over-year growth 2022-2027 (%)
7.5 Heparin - Market size and forecast 2022-2027
Exhibit 56: Chart on Heparin - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Heparin - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Heparin - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Heparin - Year-over-year growth 2022-2027 (%)
7.6 Vitamin K antagonists - Market size and forecast 2022-2027
Exhibit 60: Chart on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Aspen Pharmacare Holdings Ltd
Exhibit 120: Aspen Pharmacare Holdings Ltd - Overview
Exhibit 121: Aspen Pharmacare Holdings Ltd - Business segments
Exhibit 122: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibit 123: Aspen Pharmacare Holdings Ltd - Segment focus
12.5 AstraZeneca PLC
Exhibit 124: AstraZeneca PLC - Overview
Exhibit 125: AstraZeneca PLC - Product / Service
Exhibit 126: AstraZeneca PLC - Key news
Exhibit 127: AstraZeneca PLC - Key offerings
12.6 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 133: Boehringer Ingelheim International GmbH - Overview
Exhibit 134: Boehringer Ingelheim International GmbH - Business segments
Exhibit 135: Boehringer Ingelheim International GmbH - Key news
Exhibit 136: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 137: Boehringer Ingelheim International GmbH - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 138: Bristol Myers Squibb Co. - Overview
Exhibit 139: Bristol Myers Squibb Co. - Product / Service
Exhibit 140: Bristol Myers Squibb Co. - Key news
Exhibit 141: Bristol Myers Squibb Co. - Key offerings
12.9 Daiichi Sankyo Co. Ltd.
Exhibit 142: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 143: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 144: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 145: Daiichi Sankyo Co. Ltd. - Key offerings
12.10 Dr Reddys Laboratories Ltd.
Exhibit 146: Dr Reddys Laboratories Ltd. - Overview
Exhibit 147: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 148: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 149: Dr Reddys Laboratories Ltd. - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 150: GlaxoSmithKline Plc - Overview
Exhibit 151: GlaxoSmithKline Plc - Business segments
Exhibit 152: GlaxoSmithKline Plc - Key news
Exhibit 153: GlaxoSmithKline Plc - Key offerings
Exhibit 154: GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Exhibit 155: Johnson and Johnson Services Inc. - Overview
Exhibit 156: Johnson and Johnson Services Inc. - Business segments
Exhibit 157: Johnson and Johnson Services Inc. - Key news
Exhibit 158: Johnson and Johnson Services Inc. - Key offerings
Exhibit 159: Johnson and Johnson Services Inc. - Segment focus
12.13 LEO Pharma AS
Exhibit 160: LEO Pharma AS - Overview
Exhibit 161: LEO Pharma AS - Business segments
Exhibit 162: LEO Pharma AS - Key offerings
Exhibit 163: LEO Pharma AS - Segment focus
12.14 Novartis AG
Exhibit 164: Novartis AG - Overview
Exhibit 165: Novartis AG - Business segments
Exhibit 166: Novartis AG - Key offerings
Exhibit 167: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 168: Pfizer Inc. - Overview
Exhibit 169: Pfizer Inc. - Product / Service
Exhibit 170: Pfizer Inc. - Key news
Exhibit 171: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 172: Sanofi SA - Overview
Exhibit 173: Sanofi SA - Business segments
Exhibit 174: Sanofi SA - Key news
Exhibit 175: Sanofi SA - Key offerings
Exhibit 176: Sanofi SA - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 178: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 179: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 184: Currency conversion rates for US$
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global anticoagulants market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on DTIs - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on DTIs - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on DTIs - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on DTIs - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Heparin - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Heparin - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Heparin - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Heparin - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Aspen Pharmacare Holdings Ltd - Overview
Exhibits121: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits122: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits123: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits124: AstraZeneca PLC - Overview
Exhibits125: AstraZeneca PLC - Product / Service
Exhibits126: AstraZeneca PLC - Key news
Exhibits127: AstraZeneca PLC - Key offerings
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Boehringer Ingelheim International GmbH - Overview
Exhibits134: Boehringer Ingelheim International GmbH - Business segments
Exhibits135: Boehringer Ingelheim International GmbH - Key news
Exhibits136: Boehringer Ingelheim International GmbH - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Segment focus
Exhibits138: Bristol Myers Squibb Co. - Overview
Exhibits139: Bristol Myers Squibb Co. - Product / Service
Exhibits140: Bristol Myers Squibb Co. - Key news
Exhibits141: Bristol Myers Squibb Co. - Key offerings
Exhibits142: Daiichi Sankyo Co. Ltd. - Overview
Exhibits143: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits144: Daiichi Sankyo Co. Ltd. - Key news
Exhibits145: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits146: Dr Reddys Laboratories Ltd. - Overview
Exhibits147: Dr Reddys Laboratories Ltd. - Business segments
Exhibits148: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits149: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits150: GlaxoSmithKline Plc - Overview
Exhibits151: GlaxoSmithKline Plc - Business segments
Exhibits152: GlaxoSmithKline Plc - Key news
Exhibits153: GlaxoSmithKline Plc - Key offerings
Exhibits154: GlaxoSmithKline Plc - Segment focus
Exhibits155: Johnson and Johnson Services Inc. - Overview
Exhibits156: Johnson and Johnson Services Inc. - Business segments
Exhibits157: Johnson and Johnson Services Inc. - Key news
Exhibits158: Johnson and Johnson Services Inc. - Key offerings
Exhibits159: Johnson and Johnson Services Inc. - Segment focus
Exhibits160: LEO Pharma AS - Overview
Exhibits161: LEO Pharma AS - Business segments
Exhibits162: LEO Pharma AS - Key offerings
Exhibits163: LEO Pharma AS - Segment focus
Exhibits164: Novartis AG - Overview
Exhibits165: Novartis AG - Business segments
Exhibits166: Novartis AG - Key offerings
Exhibits167: Novartis AG - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Sanofi SA - Overview
Exhibits173: Sanofi SA - Business segments
Exhibits174: Sanofi SA - Key news
Exhibits175: Sanofi SA - Key offerings
Exhibits176: Sanofi SA - Segment focus
Exhibits177: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits178: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits179: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits180: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits181: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations